How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model

The risk to develop ACPA positive rheumatoid arthritis (RA), the most destructive type of autoimmune arthritis, is carried by HLA-DRB1 alleles containing a 5 amino acid motif: the shared epitope (SE). RA is preceded by the emergence of disease specific anti citrullinated protein antibodies (ACPA). SE positive HLA-DRB1 alleles are associated with ACPA and ACPA positive RA, not with ACPA negative RA, suggesting that ACPA contribute to the pathogenesis of RA. Understanding how HLA-DRB1 genotypes influence ACPA could lead to a curative or preventive treatment of RA. The “Shared epitope binds citrullinated peptides “ hypothesis suggests that RA associated HLA-DR alleles present citrullinated peptides to T cells that help ACPA producing B cells. The “Hapten carrier model” suggests that PAD4 is the target of the T cells which help ACPA specific B cells through a hapten carrier mechanism in which PAD4 is the carrier and citrullinated peptides are the haptens. Direct binding assay of citrullinated peptides to purified HLA-DR molecules does not support the “shared epitope binds citrullinated peptides” hypothesis. The Odds Ratios to develop ACPA positive RA associated with each of 12 common HLA-DRB1 genotypes match the probability that the two HLA-DR molecules they encode can bind at least one peptide from PAD4, not from citrullinated fibrinogen. Thus, PAD4 tolerization might stop the carrier effect and switch off production of ACPA.

[1]  I. Auger,et al.  PAD4 Immunization Triggers Anti-Citrullinated Peptide Antibodies in Normal Mice: Analysis With Peptide Arrays , 2022, Frontiers in Immunology.

[2]  I. Auger,et al.  Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins? , 2020, Journal of autoimmunity.

[3]  I. Auger,et al.  Peptidylarginine Deiminase Autoimmunity and the Development of Anti–Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten–Carrier Model , 2019, Arthritis & rheumatology.

[4]  I. Auger,et al.  Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types , 2017, Proceedings of the National Academy of Sciences.

[5]  Morten Nielsen,et al.  The Effect of a Tropical Climate on Available Nutrient Resources to Springs in Ophiolite-Hosted, Deep Biosphere Ecosystems in the Philippines , 2017, Front. Microbiol..

[6]  R. Toes,et al.  A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis , 2013, The Journal of experimental medicine.

[7]  I. Auger,et al.  New autoantibodies in early rheumatoid arthritis , 2013, Arthritis Research & Therapy.

[8]  É. Pardoux,et al.  HLA-DRB1 Genotypes and the Risk of Developing Anti Citrullinated Protein Antibody (ACPA) Positive Rheumatoid Arthritis , 2013, PloS one.

[9]  J. Norris,et al.  Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[10]  I. Auger,et al.  New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA , 2008, Annals of the rheumatic diseases.

[11]  F. Breedveld,et al.  The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[12]  M. Sebbag,et al.  Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. , 2005, Arthritis and rheumatism.

[13]  A. Suzuki,et al.  Peptidylarginine deiminase 4 (PADI4) identified as a conformation‐dependent autoantigen in rheumatoid arthritis , 2005, Scandinavian journal of rheumatology.

[14]  F. Breedveld,et al.  Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[15]  A. Sette,et al.  Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule1 , 2003, The Journal of Immunology.

[16]  P. Gregersen,et al.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[17]  I. Auger,et al.  Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen. , 2010, Arthritis and rheumatism.